Diagnostics
Ariba & Mac provides pharmaceutical R&D services in Saudi Arabia for pharmaceutical, biotechnology, nutraceutical and cosmeceutical programs that need a clearer path from product concept to a documented, transferable development package. Our scope brings formulation, analytical development, stability, validation, technical documentation and technology-transfer planning into one coordinated workstream.
R&D projects often slow down when internal laboratory capacity is limited, methods are not transfer-ready, stability data is incomplete, or scientific and regulatory teams work in separate tracks. We structure outsourced development around defined objectives, milestones, decision points and documentation so clients can reduce avoidable rework and understand what evidence is still needed before scale-up or submission.
For Saudi projects, transfer-ready R&D is increasingly important as the Kingdom expands biotechnology and local manufacturing ambitions. We plan development with the intended manufacturing route and target market in mind, including coordination for SFDA and international regulatory expectations where relevant to the program.
Pharmaceutical R&D Services: Formulation, Analytical Development & Technology Transfer
Each engagement is scoped around the product, development stage, target market and evidence required for the next technical, investment or regulatory decision.
- Generic and novel formulation development for regulated and semi-regulated markets, including dosage-form optimization and development planning.
- Pre-formulation, analytical method development and troubleshooting to support product understanding and reproducibility.
- Method and process validation, qualification, stability programs, batch documentation and technical reports.
- CTD/DMF-ready technical documentation and scientific input for patent and development records where applicable.
- Preclinical and clinical research coordination when development evidence must continue into safety or human studies.
- Technology transfer, scale-up and CMC planning with CMO/CDMO/CRO partners.
- Training and knowledge-transfer support for scientific, quality and operational teams receiving the developed process.
- Research collaboration with universities, institutes and technology partners for projects that require specialist capabilities.
Formulation & Analytical Development
Build a scientifically justified formulation and analytical package around product performance, manufacturability, stability and target specifications.
Stability, Validation & Documentation
Generate traceable methods, validation records, stability plans and development documentation that can support quality review and future regulatory work.
Transfer & Commercialization Readiness
Prepare methods, process knowledge and technical handover requirements so a receiving manufacturer or CDMO can reproduce the product with fewer avoidable transfer gaps.
Pharmaceutical R&D Process: From Product Profile to Technology Transfer
We start with the decision the client needs to make next, then work backward to define the experiments, documentation and partner activities required to reach that decision with credible evidence.
- Define the target product profile, development stage, regulatory markets, known gaps, acceptance criteria and required deliverables before laboratory work begins.
- Review data at agreed decision gates so formulation, analytical, stability and transfer activities remain aligned with the project objective and budget.
1. Scope, Product Profile & Development Plan
Review existing data, clarify intended dosage form and market, identify technical risks, and establish a development plan with milestones, responsibilities and required outputs.
2. Laboratory Execution, Review & Handover
Execute the agreed development and testing work, review results against predefined criteria, document conclusions, and prepare the next-step package for scale-up, technology transfer or regulatory planning.
Integrated Pharmaceutical R&D Consulting in Saudi Arabia
The value is not only in running experiments. It is in connecting scientific decisions to quality, regulatory, manufacturing and commercial requirements so the development package remains useful after the laboratory stage.
Scientific + Regulatory Alignment
Research, quality and regulatory considerations are reviewed together so the development plan supports both product performance and the evidence expected later in the lifecycle.
Global Partner Access, Saudi Context
Projects can combine specialist universities, laboratories, CROs and CDMOs while maintaining a single coordinated plan for Saudi and other target-market requirements.
Documentation That Travels with the Product
Development reports, methods, specifications, stability information and transfer records are structured for continuity when the program moves to another site or project phase.
Pharmaceutical R&D Scope, Evidence & Technology-Transfer Handover
We do not treat every project as the same template. Scope, partner requirements, testing needs and regulatory assumptions are confirmed at the start, and deliverables are tied to the specific product and development objective. Regulatory approvals and development outcomes remain dependent on the evidence generated and the relevant authority or receiving-site review.
Authoritative Regulatory, Government & Academic Resources
For current official requirements, standards and sector guidance, consult the relevant authority directly. These independent external resources are provided for reference and do not imply affiliation or replace project-specific regulatory, legal or clinical advice.
- SFDA Regulatory Guidelines — Official Saudi regulatory guidance relevant to pharmaceutical development and product requirements.
- ICH Quality Guidelines — International harmonized quality guidelines covering pharmaceutical development, risk management and quality systems.
- King Saud University – Center of Excellence in Biotechnology Research — Saudi academic reference for biotechnology research, training and university-industry collaboration.
FAQs About Pharmaceutical R&D Services in Saudi Arabia
Depending on the project, scope can include formulation and process development, analytical methods, stability planning, validation, troubleshooting, technical documentation, research coordination and technology-transfer preparation.
Yes. We can begin with an existing data and documentation review, identify the scientific or documentation gaps, and propose a focused plan rather than restarting work that is still usable.
Yes. The development plan can be structured around the intended Saudi manufacturing route, receiving site or CDMO, and the applicable SFDA and quality expectations identified for the project.
We define the information the receiving site needs, including methods, process parameters, material requirements, specifications, validation status, batch documentation and known process risks, then coordinate the handover with the receiving team.
Timelines vary by dosage form, existing data, testing requirements, stability needs, partner availability and the regulatory objective. We provide a milestone-based plan after reviewing the starting package.
A short product summary, development stage, available test or stability data, target market, intended manufacturing route, known technical issues and the decision or milestone you are trying to reach are usually enough to begin scoping.